Aprea Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Aprea Therapeutics

16/05/2022 15:58

* Aprea Therapeutics Inc  APRE.OQ  reported a quarterly
adjusted
loss of 36 cents​​ per share for the quarter ended in March. The
lone analyst forecast for the quarter was for a loss of 38 cents
per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Aprea Therapeutics Inc's reported EPS for the quarter was
a loss
of 36 cents​.
    * The mean earnings estimate of analysts had risen by
about 16.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Aprea Therapeutics Inc shares had fallen by 36.0% this
quarter and lost 58.5% so far this year.
    * The company reported a quarterly loss of $7.94 million.
    * Wall Street's median 12-month price target for Aprea
Therapeutics Inc is $3.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 16 at 02:58 p.m.  ​All
figures in US dollars unless otherwise stated